News
The Financial Times reports today that OpenAI co-founder Sam Altman plans to invest in new brain-computer interface (BCI) venture Merge Labs.
The company, which has been referred to as Merge Labs, is looking at an approach involving gene therapy that would modify ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results